Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
Open Access
- 1 April 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 12, 2421-2430
- https://doi.org/10.2147/ott.s200625
Abstract
The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors after treatment, multiple primary tumors are more common than before. The diagnosis and treatment of synchronous multiple primary tumors is more complicated than that of single or metachronous multiple tumors, and patients also suffer more. Because of the different conditions of these patients, lack of large-scale clinical observation data, it is necessary for clinicians to make realistic decisions on the specific conditions of patients. It is a challenge for clinicians to apply the advances of modern medicine to the diagnosis and treatment of such patients so as to prolong their survival time and improve their quality of life. This report describes the survival of an advanced elderly patient with lung, prostate and bladder cancer after receiving targeted therapy-based comprehensive treatment.Keywords
This publication has 43 references indexed in Scilit:
- Second malignancies after multiple myeloma: from 1960s to 2010sBlood, 2012
- Early clinical diagnosis of synchronous multiple primary lung cancerOncology Letters, 2011
- Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesThe Lancet Oncology, 2011
- Prevalence of multiple malignancies in the Netherlands in 2007International Journal of Cancer, 2011
- Synchronous Primary Lung Cancer and Epidermal Growth Factor Receptor MutationThe Annals of Thoracic Surgery, 2010
- Three different synchronous primary lung tumours: A case report with extensive genetic analysis and review of the literatureLung Cancer, 2008
- Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramThe Oncologist, 2007
- Primary Malignancy after Primary Female Breast Cancer in the South of the Netherlands, 1972–2001Breast Cancer Research and Treatment, 2005
- Four Primary Tumors of Lung, Bladder, Prostate, and Breast in a Male PatientSouthern Medical Journal, 2005
- Synchronous Triple Lung Cancers after Treatment for Non-Hodgkin's Lymphoma: Metachronous Quadruple CancersInternal Medicine, 2003